ADMA Biologics Inc Financial Flexibility Index
ADMA Biologics Inc financial flexibility index. ADMA Biologics Inc (ADMA) has a Financial Flexibility Index of 0.12x as of June 2026. Free cash flow of $31.80 Million (operating CF $29.54 Million minus capex $2.26 Million) represents 0% of total liabilities ($276.00 Million). Explore ADMA Biologics Inc (ADMA) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ADMA Biologics Inc (2006–2025)
Financial flexibility index of ADMA Biologics Inc from 2006 to 2025. Historical Financial Flexibility Index trend for ADMA Biologics Inc across 20 annual periods. Check ADMA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
ADMA Biologics Inc Financial Flexibility Index by Year (2006–2025)
ADMA Biologics Inc financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for ADMA Biologics Inc. For the full cash flow conversion analysis, see ADMA Biologics Inc (ADMA) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | $72.97 Million | $50.40 Million | $146.92 Million | ▼ -45.5% |
| 2024 | 0.91x | $127.25 Million | $118.67 Million | $139.66 Million | ▲ +1182.5% |
| 2023 | 0.07x | $13.78 Million | $8.80 Million | $193.98 Million | ▲ +130.6% |
| 2022 | -0.23x | $-45.60 Million | $-59.51 Million | $196.49 Million | ▲ +68.3% |
| 2021 | -0.73x | $-98.86 Million | $-112.37 Million | $135.08 Million | ▲ +2.1% |
| 2020 | -0.75x | $-89.28 Million | $-102.00 Million | $119.42 Million | ▼ -4.2% |
| 2019 | -0.72x | $-72.38 Million | $-76.19 Million | $100.90 Million | ▲ +18.2% |
| 2018 | -0.88x | $-60.58 Million | $-62.68 Million | $69.11 Million | ▼ -71.5% |
| 2017 | -0.51x | $-34.60 Million | $-37.27 Million | $67.69 Million | ▲ +20.9% |
| 2016 | -0.65x | $-18.20 Million | $-18.27 Million | $28.14 Million | ▲ +3.8% |
| 2015 | -0.67x | $-15.39 Million | $-15.42 Million | $22.89 Million | ▼ -15.2% |
| 2014 | -0.58x | $-12.38 Million | $-14.70 Million | $21.22 Million | ▲ +43.2% |
| 2013 | -1.03x | $-10.69 Million | $-10.89 Million | $10.41 Million | ▲ +7.2% |
| 2012 | -1.11x | $-6.78 Million | $-6.90 Million | $6.13 Million | ▲ +79.8% |
| 2011 | -5.47x | $-29.00K | $-29.00K | $5.31K | ▼ -243.3% |
| 2010 | -1.59x | $-19.68K | $-19.68K | $12.36K | ▲ +43.4% |
| 2009 | -2.82x | $-24.46 Million | $-24.46 Million | $8.69 Million | ▲ +60.8% |
| 2008 | -7.18x | $-19.00 Million | $-19.00 Million | $2.65 Million | ▼ -345.5% |
| 2007 | -1.61x | $-23.61 Million | $-23.61 Million | $14.65 Million | ▲ +0.0% |
| 2006 | -1.61x | $-23.61 Million | $-23.61 Million | $14.65 Million | — |